Hipertensión arterial post-COVID 19 en mujeres de edad avanzada: una secuela de alto riesgo

Brian J. Bustos-Viviescas; Carlos E. García Yerena; Amalia Villamizar Navarro; Andrea P. Lizcano Sánchez; John A. García Galviz

Autores/as

Brian J. Bustos-Viviescas Instructor del Centro de Comercio y Servicios. Servicio Nacional de Aprendizaje, Colombia https://orcid.org/0000-0002-4720-9018
Carlos E. García Yerena Docente de la Universidad del Magdalena, Colombia. https://orcid.org/0000-0002-9973-552X
Amalia Villamizar Navarro Docente de la Universidad del Atlántico, Colombia. https://orcid.org/0000-0002-5363-1776
Andrea P. Lizcano Sánchez Docente de la Universidad del Atlántico, Colombia. https://orcid.org/0000-0002-8846-2394
John A. García Galviz Docente de la Universidad de Pamplona, Colombia. https://orcid.org/0000-0003-0699-9348

Resumen

Hipertensión arterial post-COVID 19 en mujeres de edad avanzada: una secuela de alto riesgo

Descargas

Los datos de descargas todavía no están disponibles.

Citas

1. Guedes-Díaz R, González-Quijano H, Martín-Tirado J, Sánchez-Villanueva F, Domínguez-Suarez H. Preparación y enfrentamiento a la pandemia de la COVID-19. Revista Cubana de Medicina Militar. 2023 [acceso: 15/06/2023]; 52(1):e02301792. Disponible en: https://revmedmilitar.sld.cu/index.php/mil/article/view/1792

2. Sherif ZA, Gomez CR, Connors TJ, Henrich TJ, Reeves WB, RECOVER Mechanistic Pathway Task Force. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC). Elife. 2023;12:e86002. DOI: 10.7554/eLife.86002

3. Matsumoto C, Shibata S, Kishi T, Morimoto S, Mogi M, Yamamoto K, et al. Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19. Hypertens Res. 2023;46(3):601-619. DOI: 10.1038/s41440-022-01145-2

4. Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133-146. DOI: 10.1038/s41579-022-00846-2

5. Saeed S, Tadic M, Larsen TH, Grassi G, Mancia G. Coronavirus disease 2019 and cardiovascular complications: focused clinical review. J Hypertens. 2021;39(7):1282-1292. DOI: 10.1097/HJH.0000000000002819

6. Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID [published correction appears in Nat Med. 2021;27(6):1116. Nat Med. 2021;27(4):626-631. DOI: 10.1038/s41591-021-01292-y

7. Fernández-de-Las-Peñas C, Martín-Guerrero JD, Pellicer-Valero ÓJ, Navarro-Pardo E, Gómez-Mayordomo V, Cuadrado ML, et al. Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study. J Clin Med. 2022;11(2):413. DOI: 10.3390/jcm11020413

8. Maglietta G, Diodati F, Puntoni M, Lazzarelli S, Marcomini B, Patrizi L, et al. Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis. J Clin Med. 2022;11(6):1541. doi:10.3390/jcm11061541

9. Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583-590. DOI: 10.1038/s41591-022-01689-3

10. Luo Y-S, Shen X-C, Li W, Wu G-F, Yang X-M, Guo M-Y, et al. Genetic screening for hypertension and COVID-19 reveals functional variation of SPEG potentially associated with severe COVID-19 in women. Front Genet. 2023;13:1041470. DOI: 10.3389/fgene.2022.1041470